Hello and Welcome to Patientsville.com, Your Source for all RABEPRAZOLE information. We are dedicated to provide You with RABEPRAZOLE safety information. Learn about RABEPRAZOLE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
RABEPRAZOLE Safety Reports
Total RABEPRAZOLE reports: 120.RABEPRAZOLE FDA safety alerts: No.
Reported deaths: 8 Reported hospitalizations: 62.
Take RABEPRAZOLE Side Effects Survey or Share Your RABEPRAZOLE Story. Read More Here.
Showing 1-75 of 120 Next >
Pharmacist from UNITED STATES reported RABEPRAZOLE problem on Sept 26, 2006. Female patient, 65 years of age, weighting 141.1 lb, was diagnosed with dyspepsia and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DIAZEPAM, ZOLOFT, PRIMIDONE, LAMICTAL, FUROSEMIDE, PROTONIX, NORVASC, COZAAR. Patient was hospitalized. Patient recovered.RABEPRAZOLE problem was reported by a Health Professional from UNITED STATES on Sept 25, 2006. Female patient, 57 years of age, weighting 319.7 lb, was diagnosed with dyspepsia and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: back pain, condition aggravated, intervertebral disc protrusion. RABEPRAZOLE dosage: unknown. During the same period patient was treated with PREDNISONE, GAVISCON, PLAVIX, LEXAPRO, SYNTHROID, NAPROSYN, SINGULAIR. Patient was hospitalized. Patient recovered.
Physician from BRAZIL reported RABEPRAZOLE problem on Oct 03, 2006. Male patient, 45 years of age, weighting 112.4 lb, was diagnosed with gastrooesophageal reflux disease and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, gingival bleeding, gingival pain, headache, synovial cyst. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with MOTILIUM, IRON, FOLIC ACID. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from JAPAN on Oct 13, 2006. Male patient, 79 years of age, weighting 112.4 lb, was diagnosed with reflux oesophagitis and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: hypergastrinaemia. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with NORVASC, ASPIRIN, NAUZELIN, EPADEL S. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RABEPRAZOLE problem on Oct 16, 2006. Female patient, 83 years of age, was diagnosed with reflux oesophagitis, ascites, hyperuricaemia and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, anaemia, condition aggravated, depressed level of consciousness, disseminated intravascular coagulation, gastrooesophageal reflux disease, hepatitis c, hiatus hernia, liver disorder. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with LASIX, ALLOPURINOL, ALDACTONE, URSO, JUVELA N, LIVACT, LAXOBERON, FOLIC ACID. Patient died on 09/03/2006.
RABEPRAZOLE problem was reported by a Physician from JAPAN on Oct 16, 2006. Male patient, 67 years of age, weighting 149.9 lb, was diagnosed with gastric ulcer haemorrhage and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood sodium decreased, chills, granulocytopenia, hepatic function abnormal. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SELBEX. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported RABEPRAZOLE problem on Oct 18, 2006. Female patient was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. RABEPRAZOLE dosage: unknown. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from UNITED STATES on Oct 20, 2006. Male patient, 38 years of age, weighting 172.0 lb, was diagnosed with dyspepsia and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, decubitus ulcer, gastrooesophageal reflux disease. RABEPRAZOLE dosage: unknown. During the same period patient was treated with VANCOMYCIN, ANTIBIOTIC, PANAPHIL OINTMENT, CIPRO. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RABEPRAZOLE problem on Oct 24, 2006. Male patient, 67 years of age, weighting 149.9 lb, was diagnosed with gastric ulcer haemorrhage and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood sodium decreased, chills, granulocytopenia, hepatic function abnormal, pyrexia. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SELBEX, LENDORMIN D, SANMEL, ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE, THROMBIN LOCAL SOLUTION, ESIDRI, RIZE. Patient was hospitalized. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from JAPAN on Sept 28, 2006. Male patient, 57 years of age, weighting 189.6 lb, was diagnosed with reflux oesophagitis and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: nasal congestion, nasal polyps, sinusitis. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FLUNASE, URALYT, ALLOZYM, TOWK, METHYCOBAL, ADETPHOS, MOHRUS TAPE. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported RABEPRAZOLE problem on Nov 03, 2006. Male patient was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gastric polyps. RABEPRAZOLE dosage: unknown. During the same period patient was treated with NEXIUM. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from AUSTRALIA on Oct 31, 2006. Male patient, 56 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, headache, malaise. RABEPRAZOLE dosage: 20 MG, ORAL. Patient recovered.
Health Professional from BRAZIL reported RABEPRAZOLE problem on Oct 31, 2006. Female patient, 26 years of age, weighting 136.7 lb, was diagnosed with gastric disorder and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: pulmonary hypertension. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with CHLORTALIDONE, DIGOXIN, RANITIDINE, FUROSEMIDE, PLASIL, DRAMIN, SUPERAN, SPIROLACTONE. Patient died on 10/23/2006.
RABEPRAZOLE problem was reported by a Physician from JAPAN on Nov 09, 2006. Female patient, 44 years of age, was diagnosed with gastric ulcer, back pain and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, back pain, blood culture positive, disseminated intravascular coagulation, enterobacter infection, oral intake reduced, septic shock. RABEPRAZOLE dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with CEROCRAL, OXYCONTIN, MAGMIT, YODEL, ROHIPNOL, FLUNITRAZEPAM, GASMOTIN, INDOMETHACIN. Patient recovered.
Pharmacist from CANADA reported RABEPRAZOLE problem on Nov 03, 2006. Male patient, 22 years of age, was diagnosed with gastric disorder and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: agitation, hallucinations, mixed, intentional overdose, psychotic disorder. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from CANADA on Nov 03, 2006. Female patient, 33 years of age, weighting 211.6 lb, was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, diarrhoea, mood swings. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FUROSEMIDE, METOPROLOL TARTRATE, FOLIC ACID, REPLIVITE, TRIPTOSIL. Patient recovered.
Health Professional from JAPAN reported RABEPRAZOLE problem on Oct 25, 2006. Male patient, 57 years of age, weighting 189.6 lb, was diagnosed with reflux oesophagitis and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: chronic sinusitis, condition aggravated, nasal congestion, nasal polyps, nasal septum deviation. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FLUNASE, URALYT, ALLOZYM, TOWK, METHYCOBAL, ADETPHOS, MOHRUS TAPE. Patient was hospitalized. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from JAPAN on Nov 09, 2006. Female patient, 44 years of age, was diagnosed with gastric ulcer, back pain and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, back pain, blood culture positive, blood pressure decreased, chills, disseminated intravascular coagulation, enterobacter infection, pyrexia. RABEPRAZOLE dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with CEROCRAL, OXYCONTIN, MAGMIT, YODEL, ROHIPNOL, FLUNITRAZEPAM, GASMOTIN, INDOMETHACIN. Patient recovered.
Physician from AUSTRALIA reported RABEPRAZOLE problem on Nov 13, 2006. Male patient, 58 years of age, was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gastric polyps. RABEPRAZOLE dosage: unknown. During the same period patient was treated with NEXIUM, OMEPRAZOLE. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from JAPAN on Nov 08, 2006. Female patient, 44 years of age, was diagnosed with gastric ulcer, back pain and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, back pain, chills, disseminated intravascular coagulation, enterobacter infection, pyrexia, septic shock. RABEPRAZOLE dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with CEROCRAL, OXYCONTIN, MAGMIT, YODEL, ROHIPNOL, FLUNITRAZEPAM, GASMOTIN, INDOMETHACIN. Patient recovered.
Pharmacist from CANADA reported RABEPRAZOLE problem on Nov 29, 2006. Male patient, 22 years of age, was diagnosed with gastric disorder and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: agitation, hallucinations, mixed, intentional overdose, psychotic disorder. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from JAPAN on Dec 13, 2006. Female patient, 44 years of age, was diagnosed with gastric ulcer, back pain and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, anorexia, anxiety, back pain, blood culture positive, blood pressure decreased, disseminated intravascular coagulation, enterobacter infection, septic shock. RABEPRAZOLE dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with CEROCRAL, OXYCONTIN, MAGMIT, YODEL, ROHIPNOL, FLUNITRAZEPAM, GASMOTIN, INDOMETHACIN. Patient recovered.
Consumer or non-health professional from BRAZIL reported RABEPRAZOLE problem on Mar 26, 2007. Female patient, 46 years of age, weighting 143.3 lb, was diagnosed with reflux oesophagitis, constipation and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dehydration, diarrhoea, flatulence, malaise, mouth ulceration, oedema mouth, oral discomfort, oral pain. RABEPRAZOLE dosage: unknown. During the same period patient was treated with ZELNORM. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from BRAZIL on Mar 29, 2007. Female patient, 46 years of age, weighting 143.3 lb, was diagnosed with reflux oesophagitis, constipation and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dehydration, diarrhoea, flatulence, malaise, mouth ulceration, oedema mouth, oral discomfort, oral pain. RABEPRAZOLE dosage: unknown. During the same period patient was treated with ZELNORM. Patient recovered.
Physician from BRAZIL reported RABEPRAZOLE problem on Apr 11, 2007. Female patient, 46 years of age, weighting 143.3 lb, was diagnosed with reflux oesophagitis, constipation and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dehydration, diarrhoea, flatulence, malaise, mouth ulceration, oedema mouth, oral discomfort, oral pain. RABEPRAZOLE dosage: unknown. During the same period patient was treated with ZELMAC. Patient recovered.
RABEPRAZOLE problem was reported by a Pharmacist from AUSTRALIA on June 29, 2007. Male patient was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, depression, suicidal ideation. RABEPRAZOLE dosage: unknown. During the same period patient was treated with SIMVASTATIN, FUROSEMIDE, IRBISARTAN, OLANZAPINE, MIRTAZAPINE, OXAZEPAM, ATORVASTATIN CALCIUM. Patient recovered.
Pharmacist from UNITED STATES reported RABEPRAZOLE problem on June 22, 2007. Male patient, 30 years of age, was diagnosed with dyspepsia and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, headache, liver function test abnormal, tooth disorder. RABEPRAZOLE dosage: unknown. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from UNITED STATES on July 09, 2007. Female patient, 55 years of age, was diagnosed with abdominal pain upper, dyspepsia, flatulence and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease, helicobacter gastritis, sleep terror. RABEPRAZOLE dosage: 20 MG, IN THE MORNING, ORAL. Patient recovered.
Health Professional from FRANCE reported RABEPRAZOLE problem on July 12, 2007. Male patient, 19 years of age, was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: renal failure acute. RABEPRAZOLE dosage: unknown. During the same period patient was treated with CARTREX, ACETAMINOPHEN, LUMIRELAX. Patient was hospitalized. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from JAPAN on July 10, 2007. Male patient, 67 years of age, was diagnosed with duodenal ulcer and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: neck pain, pain in extremity. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PRAVASTATIN, BUFFERIN, URINORM, PERSANTIN, MARZULENE, LEVOFLOXACIN. Patient recovered.
Pharmacist from CANADA reported RABEPRAZOLE problem on July 06, 2007. Male patient, 30 years of age, was diagnosed with dyspepsia and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, liver function test abnormal. RABEPRAZOLE dosage: unknown. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from UNITED STATES on July 11, 2007. Female patient, 59 years of age, weighting 165.3 lb, was diagnosed with gastrointestinal disorder and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: acne, blister, musculoskeletal discomfort, oral mucosal blistering, skin reaction, tongue exfoliation. RABEPRAZOLE dosage: 20 MG, ORAL. During the same period patient was treated with DOMPERIDONE, INDAPAMIDE, IBUPROFEN. Patient recovered.
Health Professional from SPAIN reported RABEPRAZOLE problem on July 04, 2007. Male patient, 36 years of age, weighting 178.6 lb, was diagnosed with peptic ulcer, spondyloarthropathy and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gynaecomastia. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FENTANYL, DACORTIN, ATACAND, TRAVATAN, TIMOFTOL, CLAVERSAL, ACTONEL, NATECAL. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from SPAIN on July 04, 2007. Male patient, 36 years of age, weighting 178.6 lb, was diagnosed with peptic ulcer, spondyloarthropathy and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: gynaecomastia. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FENTANYL, DARCOTIN, ATACAND, TRAVATAN, TIMOFTOL, CLAVERSAL, ACTONEL, NATECAL. Patient recovered.
Consumer or non-health professional from CANADA reported RABEPRAZOLE problem on July 17, 2007. Female patient, weighting 6.61 lb, was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: cardiac murmur, neonatal disorder, premature baby. RABEPRAZOLE dosage: 20 MG, 2 IN 1 D, TRANSPLACENTAL. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from GERMANY on July 23, 2007. Female patient, 69 years of age, weighting 209.4 lb, was diagnosed with reflux oesophagitis and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: conjunctivitis, headache, skin exfoliation. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. Patient recovered.
Physician from AUSTRALIA reported RABEPRAZOLE problem on July 12, 2007. Male patient, 48 years of age, weighting 163.1 lb, was diagnosed with gastrooesophageal reflux disease and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: bone density decreased. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from JAPAN on July 23, 2007. Male patient, 67 years of age, was diagnosed with duodenal ulcer and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: neck pain, pain in extremity. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PRAVASTATIN, BUFFERIN, URINORM, PERSANTIN, MARZULENE, LEVOFLOXACIN. Patient recovered.
Physician from JAPAN reported RABEPRAZOLE problem on July 30, 2007. Male patient, 67 years of age, was diagnosed with duodenal ulcer and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: neck pain, pain in extremity. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PRAVASTATIN, BUFFERIN, URINORM, PERSANTIN, MARZULENE, LEVOFLOXACIN. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from JAPAN on July 26, 2007. Female patient, 78 years of age, weighting 77.16 lb, was diagnosed with gastric ulcer, helicobacter infection and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. RABEPRAZOLE dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, MAGMITT. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RABEPRAZOLE problem on Aug 06, 2007. Male patient, 64 years of age, was diagnosed with reflux oesophagitis and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: memory impairment, metastases to central nervous system, neoplasm malignant. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
RABEPRAZOLE problem was reported by a Health Professional from JAPAN on Aug 09, 2007. Female patient, 78 years of age, weighting 77.16 lb, was diagnosed with gastric ulcer, helicobacter infection and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. RABEPRAZOLE dosage: 20 MG, 2 IN 1 D, ORAL. During the same period patient was treated with AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, MAGMITT. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported RABEPRAZOLE problem on Aug 28, 2007. Female patient, 30 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: foetal growth retardation, foetal movements decreased, pregnancy. RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. Patient recovered.
RABEPRAZOLE problem was reported by a Physician from SPAIN on Sept 18, 2007. Male patient, 74 years of age, weighting 132.3 lb, was diagnosed with prophylaxis and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: metastases to bone, prostate cancer. RABEPRAZOLE dosage: 20 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DURAGESIC, HALOPERIDOL, CELEBREX, DACORTIN, DISTRANEURINE, MEGAPREN, CARDIL, OPONAF. Patient died on 08/24/2007.
Physician from ITALY reported RABEPRAZOLE problem on Sept 14, 2007. Female patient, 74 years of age, was diagnosed with ulcer, dyslipidaemia and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: amnesia, brain scan abnormal, confusional state, dyslexia, gait disturbance, movement disorder, tremor. RABEPRAZOLE dosage: 10 MG,. During the same period patient was treated with ATORVASTATIN CALCIUM, CLOPIDOGREL, ACETYLSALICYLIC ACID SRT, RAMIPRIL, SALMETEROL, CLEBOPRIDE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 120 Next >